BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30677768)

  • 41. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
    Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
    J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oesophageal involvement in mantle cell lymphoma.
    Santra G
    Singapore Med J; 2010 Dec; 51(12):e201-3. PubMed ID: 21221493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deferred therapy is associated with improved overall survival in patients with newly diagnosed mantle cell lymphoma.
    Cohen JB; Han X; Jemal A; Ward EM; Flowers CR
    Cancer; 2016 Aug; 122(15):2356-63. PubMed ID: 27153197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 18F-FDG PET/CT Cannot Substitute Endoscopy in the Staging of Gastrointestinal Involvement in Mantle Cell Lymphoma. A Retrospective Multi-Center Cohort Analysis.
    Skrypets T; Ferrari C; Nassi L; Margiotta Casaluci G; Puccini B; Mannelli L; Filonenko K; Kryachok I; Clemente F; Vegliante MC; Daniele A; Sacchetti G; Guarini A; Minoia C
    J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33668644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients.
    Matutes E; Parry-Jones N; Brito-Babapulle V; Wotherspoon A; Morilla R; Atkinson S; Elnenaei MO; Jain P; Giustolisi GM; A'Hern RP; Catovsky D
    Leuk Lymphoma; 2004 Oct; 45(10):2007-15. PubMed ID: 15370245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results from the Belgian mantle cell lymphoma registry.
    Vergote V; Janssens A; André M; Bonnet C; Van Hende V; Van Den Neste E; Van Eygen K; Maerevoet M; Pranger D; Schroyens W; Debussche S; Maertens V; Beel K; Lemmens J; Caron C; Delrieu V; Van Den Broeck I; Vanstraelen G; Jacquy C; Schauvlieghe L; De Samblanx H; Madoe V; Meers S; Boulet D; Verhoef G; Van Hoof A
    Acta Clin Belg; 2017 Jun; 72(3):172-178. PubMed ID: 28222652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complex karyotype is associated with aggressive disease and shortened progression-free survival in patients with newly diagnosed mantle cell lymphoma.
    Cohen JB; Ruppert AS; Heerema NA; Andritsos LA; Jones JA; Porcu P; Baiocchi R; Christian BA; Byrd JC; Flynn J; Penza S; Devine SM; Blum KA
    Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):278-285.e1. PubMed ID: 25660723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic stem cell support in fit patients with mantle cell lymphoma: 20 years of single-center experience.
    Widmer F; Balabanov S; Soldini D; Samaras P; Gerber B; Manz MG; Goede JS
    Ann Hematol; 2018 Feb; 97(2):277-287. PubMed ID: 29147847
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma.
    Nastoupil LJ; Shenoy PJ; Ambinder A; Koff JL; Nooka AK; Waller EK; Langston A; Seward M; Kaufman JL; Bernal-Mizrachi L; King N; Lechowicz MJ; Lonial S; Sinha R; Flowers CR
    Leuk Lymphoma; 2015 Feb; 56(2):383-9. PubMed ID: 24828864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital.
    Bernard M; Tsang RW; Le LW; Hodgson DC; Sun A; Wells W; Kukreti V; Kuruvilla J; Crump M; Gospodarowicz MK
    Leuk Lymphoma; 2013 Feb; 54(2):261-7. PubMed ID: 22793378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
    Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
    Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma.
    Joao C; Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Gastineau DA; Markovic SN
    Bone Marrow Transplant; 2006 May; 37(9):865-71. PubMed ID: 16532015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endoscopic diagnosis of a colonic localisation of a mantle cell lymphoma.
    Lambrechts C; Van der Wijst E; Bries G; Bogaert J; De Schepper H; Van Hauthem P; Schoeters P; De Maeyer M
    Acta Gastroenterol Belg; 2022; 85(4):632-634. PubMed ID: 36566373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.
    Foran JM; Rohatiner AZ; Cunningham D; Popescu RA; Solal-Celigny P; Ghielmini M; Coiffier B; Johnson PW; Gisselbrecht C; Reyes F; Radford JA; Bessell EM; Souleau B; Benzohra A; Lister TA
    J Clin Oncol; 2000 Jan; 18(2):317-24. PubMed ID: 10637245
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early lymph node involvement by mantle cell lymphoma limited to the germinal center: report of a case with a novel "follicular in situ" growth pattern.
    Edlefsen KL; Greisman HA; Yi HS; Mantei KM; Fromm JR
    Am J Clin Pathol; 2011 Aug; 136(2):276-81. PubMed ID: 21757601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
    Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L
    Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autotransplantation for mantle cell lymphoma.
    Vose JM
    Cancer J; 2012; 18(5):427-31. PubMed ID: 23006947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome.
    Cogliatti SB; Bertoni F; Zimmermann DR; Henz S; Diss TC; Ghielmini M; Schmid U
    J Pathol; 2005 Jul; 206(3):320-7. PubMed ID: 15887292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Expression of SOX11 mRNA in mantle cell lymphoma and its clinical significance].
    Wang YY; Yu Z; Yi SH; Li ZJ; Li CH; Xie ZQ; Li F; Zang MR; Hao M; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):556-60. PubMed ID: 22967417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index.
    Sarkozy C; Terré C; Jardin F; Radford I; Roche-Lestienne C; Penther D; Bastard C; Rigaudeau S; Pilorge S; Morschhauser F; Bouscary D; Delarue R; Farhat H; Rousselot P; Hermine O; Tilly H; Chevret S; Castaigne S
    Genes Chromosomes Cancer; 2014 Jan; 53(1):106-16. PubMed ID: 24249260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.